{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:43:40Z","timestamp":1771065820640,"version":"3.50.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":1920,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim Vetmedica GmbH, Germany","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open access funding enabled and organized by Projekt DEAL"},{"name":"Open access funding enabled and organized by Projekt DEAL."},{"name":"Open access funding enabled and organized by Projekt DEAL."},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Idiopathic head tremor syndrome is a paroxysmal movement disorder of unknown etiology. Spontaneous remission may occur, but owners may request treatment in severely affected dogs with continued episodes. Controlled studies of the disease are not available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>A drug with gamma amino butyric acid-ergic and anxiolytic effects will decrease head tremor episodes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Twenty-four dogs with severe nonremitting head tremor and presumptive clinical diagnosis of idiopathic head tremor syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective, blinded, placebo-controlled clinical trial to compare imepitoin with placebo in dogs with frequent episodes of idiopathic head tremor. Evaluation of efficacy used the quotient T2\/T1 that represented prolongation of the head tremor-free period compared to a 3-month baseline. A dog was considered a responder if tremors subsided or if the head tremor-free period was 3\u00d7 longer than the longest period during baseline (T2\/T1\u2009\u2265\u20093). Sample size calculations considered a large effect of imepitoin on T2\/T1 (Cohen's d = 0.8).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were no responders in the placebo group (0\/12). In the imepitoin group, the responder rate was 17% (2\/12; P = .18) with T2\/T1 3.8 and 4.0. Mean T2\/T1 was 1.0\u2009\u00b1\u20091.4 in the imepitoin and 0.4\u2009\u00b1\u20090.4 in the placebo group (P = .37).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and Clinical Importance<\/jats:title>\n                    <jats:p>Imepitoin did not result in a significant overall benefit. Future studies should focus on treatment of subgroups with a common pathophysiology and similar comorbidities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.15955","type":"journal-article","created":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T05:29:56Z","timestamp":1604726996000},"page":"2571-2581","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Imepitoin for treatment of idiopathic head tremor syndrome in dogs: A randomized, blinded, placebo-controlled study"],"prefix":"10.1093","volume":"34","author":[{"given":"Nina","family":"Schneider","sequence":"first","affiliation":[{"name":"Centre for Clinical Veterinary Medicine, LMU Munich , Munich,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidrun","family":"Potschka","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, Toxicology, and Pharmacy, LMU Munich , Munich,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4605-9791","authenticated-orcid":false,"given":"Sven","family":"Reese","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine, LMU Munich Department of Veterinary Sciences, , Munich,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3113-5659","authenticated-orcid":false,"given":"Franziska","family":"Wielaender","sequence":"additional","affiliation":[{"name":"Centre for Clinical Veterinary Medicine, LMU Munich , Munich,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7094-1947","authenticated-orcid":false,"given":"Andrea","family":"Fischer","sequence":"additional","affiliation":[{"name":"Centre for Clinical Veterinary Medicine, LMU Munich , Munich,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,1]]},"reference":[{"key":"2026020922123309600_jvim15955-bib-0001","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/mds.23936","article-title":"An inherited episodic head tremor syndrome in Doberman Pinscher dogs","volume":"26","author":"Wolf","year":"2011","journal-title":"Mov Disord"},{"key":"2026020922123309600_jvim15955-bib-0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/165463","article-title":"Clinical and breed characteristics of idiopathic head tremor syndrome in 291 dogs: a retrospective study","volume":"2015","author":"Shell","year":"2015","journal-title":"Vet Med Int"},{"key":"2026020922123309600_jvim15955-bib-0003","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/mds.25767","article-title":"Idiopathic head tremor in English Bulldogs","volume":"29","author":"Guevar","year":"2014","journal-title":"Mov Disord"},{"key":"2026020922123309600_jvim15955-bib-0004","first-page":"516","article-title":"Classifying involuntary muscle contractions","volume":"28","author":"De Lahunta","year":"2006","journal-title":"Compend Contin Educ Pract Vet"},{"key":"2026020922123309600_jvim15955-bib-0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tvjl.2016.05.011","article-title":"Classification of involuntary movements in dogs: tremors and twitches","volume":"214","author":"Lowrie","year":"2016","journal-title":"Vet J"},{"key":"2026020922123309600_jvim15955-bib-0006","article-title":"London: European Medicines Agency 2018. Summery of the EPAR for Pexion","author":"EMA","year":"2017"},{"key":"2026020922123309600_jvim15955-bib-0007","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-017-1098-0","article-title":"The use of imepitoin (Pexion\u2122) on fear and anxiety related problems in dogs \u2013 a case series","volume":"13","author":"McPeake","year":"2017","journal-title":"BMC Vet Res"},{"issue":"6","key":"2026020922123309600_jvim15955-bib-0008","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1111\/jvim.15608","article-title":"Effectiveness of imepitoin for the control of anxiety and fear associated with noise phobia in dogs","volume":"33","author":"Engel","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020922123309600_jvim15955-bib-0009","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-015-0465-y","article-title":"International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy","volume":"11","author":"Potschka","year":"2015","journal-title":"BMC Vet Res"},{"key":"2026020922123309600_jvim15955-bib-0010","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*power 3.1: tests for correlation and regression analyses","volume":"41","author":"Erdfelder","year":"2009","journal-title":"Behav Res Methods"},{"key":"2026020922123309600_jvim15955-bib-0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-118","article-title":"Handling missing data in RCTs; a review of the top medical journals","volume":"14","author":"Bell","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2026020922123309600_jvim15955-bib-0012","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"2026020922123309600_jvim15955-bib-0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eplepsyres.2016.02.002","article-title":"Response to placebo in clinical epilepsy trials-old ideas and new insights","volume":"122","author":"Goldenholz","year":"2016","journal-title":"Epilepsy Res"},{"key":"2026020922123309600_jvim15955-bib-0014","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.208","article-title":"The nocebo effect of drugs","volume":"4","author":"Plan\u00e8s","year":"2016","journal-title":"Pharmacol Res Perspect"},{"key":"2026020922123309600_jvim15955-bib-0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2018.00188","article-title":"GABAA receptor availability changes underlie symptoms in isolated cervical dystonia","volume":"9","author":"Berman","year":"2018","journal-title":"Front Neurol"},{"key":"2026020922123309600_jvim15955-bib-0016","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nicl.2017.10.011","article-title":"Loss of inhibition in sensorimotor networks in focal hand dystonia","volume":"17","author":"Gallea","year":"2018","journal-title":"NeuroImage Clin"},{"key":"2026020922123309600_jvim15955-bib-0017","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fvets.2015.00065","article-title":"Dystonia and paroxysmal dyskinesias: under-recognized movement disorders in domestic animals? A comparison with human dystonia\/paroxysmal dyskinesias","volume":"2","author":"Richter","year":"2015","journal-title":"Front Vet Sci"},{"key":"2026020922123309600_jvim15955-bib-0018","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1528-1167.2006.00607.x","article-title":"Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs","volume":"47","author":"L\u00f6scher","year":"2006","journal-title":"Epilepsia"},{"key":"2026020922123309600_jvim15955-bib-0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12917-015-0464-z","article-title":"International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe","volume":"11","author":"Bhatti","year":"2015","journal-title":"BMC Vet Res"},{"key":"2026020922123309600_jvim15955-bib-0020","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1111\/jvim.15608","article-title":"Effectiveness of imepitoin for the control of anxiety and fear associated with noise phobia in dogs","volume":"33","author":"Engel","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020922123309600_jvim15955-bib-0021","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40263-013-0129-z","article-title":"The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy","volume":"28","author":"Rundfeldt","year":"2014","journal-title":"CNS Drugs"},{"key":"2026020922123309600_jvim15955-bib-0022","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/jvim.14789","article-title":"Diagnostic utility of wireless video-electroencephalography in unsedated dogs","volume":"31","author":"James","year":"2017","journal-title":"J Vet Intern Med"},{"key":"2026020922123309600_jvim15955-bib-0023","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.27121","article-title":"Consensus statement on the classification of tremors. From the task force on tremor of the International Parkinson and Movement Disorder Society","volume":"33","author":"Bhatia","year":"2018","journal-title":"Mov Disord"},{"key":"2026020922123309600_jvim15955-bib-0024","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/ane.13101","article-title":"Neuroimaging and neuropathological findings in essential tremor","volume":"139","author":"Mavroudis","year":"2019","journal-title":"Acta Neurol Scand"},{"key":"2026020922123309600_jvim15955-bib-0025","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.parkreldis.2012.04.024","article-title":"Gaba and serotonin molecular neuroimaging in essential tremor: a clinical correlation study","volume":"18","author":"Gironell","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"2026020922123309600_jvim15955-bib-0026","doi-asserted-by":"crossref","DOI":"10.1186\/s40673-020-00116-y","article-title":"A pilot study of essential tremor: cerebellar GABA+\/Glx ratio is correlated with tremor severity","volume":"7","author":"Tapper","year":"2020","journal-title":"Cerebellum Ataxias"},{"key":"2026020922123309600_jvim15955-bib-0027","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.mcna.2018.10.016","article-title":"Essential tremor","volume":"103","author":"Reich","year":"2019","journal-title":"Med Clin North Am"},{"key":"2026020922123309600_jvim15955-bib-0028","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurol.2016.07.014","article-title":"Essential tremor: update of therapeutic strategies (medical treatment and gamma knife thalamotomy)","volume":"172","author":"Witjas","year":"2016","journal-title":"Rev Neurol (Paris)"},{"key":"2026020922123309600_jvim15955-bib-0029","first-page":"1","article-title":"Reviews dystonia and tremor: the clinical syndromes with isolated tremor","volume":"6","author":"Albanese","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"2026020922123309600_jvim15955-bib-0030","first-page":"130","article-title":"Textbook of Veterinary Internal Medicine Expert Consult","author":"Rusbridge","year":"2017","edition":"8"},{"key":"2026020922123309600_jvim15955-bib-0031","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncl.2014.09.002","article-title":"Diagnosis and treatment of dystonia","volume":"33","author":"Jinnah","year":"2015","journal-title":"Neurol Clin"},{"key":"2026020922123309600_jvim15955-bib-0032","first-page":"1211","article-title":"Dystonia","volume":"2014","author":"Snaith","year":"2014","journal-title":"BMJ Clin Evid"},{"key":"2026020922123309600_jvim15955-bib-0033","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5334\/tohm.272","article-title":"Early illustrations of geste antagoniste in cervical and generalized dystonia","volume":"5","author":"Broussolle","year":"2015","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"2026020922123309600_jvim15955-bib-0034","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/mds.25501","article-title":"Psychiatric comorbidities in dystonia: emerging concepts","volume":"28","author":"Zurowski","year":"2013","journal-title":"Mov Disord"},{"key":"2026020922123309600_jvim15955-bib-0035","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1080\/15622975.2018.1468030","article-title":"Anxiolytics targeting GABA a receptors: insights on etifoxine","volume":"19","author":"Poisbeau","year":"2018","journal-title":"World J Biol Psychiatry"},{"key":"2026020922123309600_jvim15955-bib-0036","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/jvim.15402","article-title":"Seizure-precipitating factors in dogs with idiopathic epilepsy","volume":"33","author":"Forsg\u00e5rd","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020922123309600_jvim15955-bib-0037","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/vr.104051","article-title":"Phenobarbital administration every eight hours: improvement of seizure management in idiopathic epileptic dogs with decreased phenobarbital elimination half-life","volume":"180","author":"Stabile","year":"2017","journal-title":"Vet Rec"},{"key":"2026020922123309600_jvim15955-bib-0038","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"2026020922123309600_jvim15955-bib-0039","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.WNL.0000123695.22623.32","article-title":"Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"62","author":"French","year":"2004","journal-title":"Neurology"},{"key":"2026020922123309600_jvim15955-bib-0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-018-1386-3","article-title":"Systematic review of antiepileptic drugs' safety and effectiveness in feline epilepsy","volume":"14","author":"Charalambous","year":"2018","journal-title":"BMC Vet Res"},{"key":"2026020922123309600_jvim15955-bib-0041","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-014-0257-9","article-title":"Treatment in canine epilepsy \u2013 a systematic review","volume":"10","author":"Charalambous","year":"2014","journal-title":"BMC Vet Res"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.15955","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.15955","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/34\/6\/2571\/66661264\/jvim15955.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/34\/6\/2571\/66661264\/jvim15955.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:23:27Z","timestamp":1770693807000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/34\/6\/2571\/8448399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.15955","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,11,1]]},"assertion":[{"value":"2020-08-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}